Search

Filters
Clear All
  • 8
  • 17
  • 81

Phase

  • 4
  • 3
  • 20
  • 3
  • 22
  • 1
  • 52
  • 105
  • 14

Found 106 will-simon trials

A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
R
Rohan Maniar
18 years - 100 years
All genders
This study investigates the use of an investigational medication in treating people with early-stage non-small cell lung cancer (NSCLC) after surgery. NSCLC is a type of lung cancer that occurs when cells in the lung grow uncontrollably. The purpose of this study is to see if the investigational medication can …
H
Hristos Kaimakliotis, MD
18 years - 100 years
All genders
This study investigates the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) for patients with recurrent non-muscle invasive bladder cancer. Non-muscle invasive bladder cancer is a type of cancer that affects the bladder but does not invade the muscle layer. Gemcitabine is a chemotherapy drug that stops cancer …
T
Tareq Salous
18 years - 100 years
All genders
Phase 3
This study investigates how well an investigational medication combination works in treating adults with untreated locally advanced or metastatic urothelial carcinoma with an FGFR3 genetic alteration. Urothelial carcinoma is a type of cancer that occurs in the urinary system. This study uses a combination of medications, including monoclonal antibodies, which …
S
Sharon E. Robertson
18 years - 100 years
Female
Phase 3
This study investigates treatment options for high risk locally advanced cervical cancer, where the cancer has spread to nearby tissues or lymph nodes. The study compares two approaches: one with induction chemotherapy using an investigational medication and chemotherapy, followed by chemoradiation and maintenance therapy, and the other with just chemoradiation …
A
Anita Turk, MD
18 years - 100 years
All genders
Phase 3
This study investigates treatments for metastatic colorectal cancer, which is a type of cancer that starts in the colon or rectum and spreads to other parts of the body. The purpose of this study is to compare two treatments: one using an investigational medication with a chemotherapy regimen called mFOLFOX6, …
V
Varun Mittal
18 years - 100 years
All genders
This study investigates the use of an investigational medication in patients with large B-cell lymphoma (LBCL) who have minimal residual disease after completing first-line therapy. Large B-cell lymphoma is a type of cancer that affects white blood cells. The purpose of this study is to compare the effects of a …
T
Tarah Ballinger, MD
18 years - 100 years
All genders
This study investigates the effects of an investigational treatment regimen combined with a checkpoint inhibitor on patients with advanced metastatic breast cancer. Metastatic breast cancer is when cancer cells spread from the breast to other parts of the body. The study compares this combination treatment to the usual treatment chosen …
A
Attaya Suvannasankha, MD
18 years - 100 years
All genders
Phase 2
This study investigates the effects of an investigational medication combined with dexamethasone on people with relapsed or refractory multiple myeloma. Multiple myeloma is a type of cancer that affects plasma cells in the bone marrow, which are important for the immune system. This condition can cause symptoms like bone pain, …
 Engaging your Brain for Memory Function
S
Simon Davis
18 years - 80 years
Accepts healthy volunteer
All genders
Join Us and Take Part in Brain Activity Research at Indiana University!Your brain is always working—helping you think, remember, and make decisions. This study is looking at how different parts of the brain work together.We are also studying a safe, non-invasive method called TMS (transcranial magnetic stimulation) to see how …
M
Mateusz Opyrchal, MD, PhD
18 years or above
All genders
Observational
What is the purpose of this study?The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validatehis process and to predict responses to therapies and use it to choose the …
51 - 60 of 106